rs213501
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145716.4(SSBP3):c.276+4864C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 152,082 control chromosomes in the GnomAD database, including 18,301 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.47 ( 18301 hom., cov: 33)
Consequence
SSBP3
NM_145716.4 intron
NM_145716.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.48
Publications
1 publications found
Genes affected
SSBP3 (HGNC:15674): (single stranded DNA binding protein 3) Predicted to enable single-stranded DNA binding activity and transcription coactivator activity. Predicted to be involved in head development and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be part of protein-containing complex. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.699 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SSBP3 | NM_145716.4 | c.276+4864C>G | intron_variant | Intron 4 of 17 | ENST00000610401.6 | NP_663768.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SSBP3 | ENST00000610401.6 | c.276+4864C>G | intron_variant | Intron 4 of 17 | 5 | NM_145716.4 | ENSP00000479674.2 |
Frequencies
GnomAD3 genomes AF: 0.465 AC: 70694AN: 151964Hom.: 18275 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
70694
AN:
151964
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.465 AC: 70776AN: 152082Hom.: 18301 Cov.: 33 AF XY: 0.463 AC XY: 34429AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
70776
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
34429
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
29255
AN:
41480
American (AMR)
AF:
AC:
5632
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1910
AN:
3460
East Asian (EAS)
AF:
AC:
2767
AN:
5156
South Asian (SAS)
AF:
AC:
1681
AN:
4818
European-Finnish (FIN)
AF:
AC:
3987
AN:
10590
Middle Eastern (MID)
AF:
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24156
AN:
67976
Other (OTH)
AF:
AC:
956
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1802
3604
5407
7209
9011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1505
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.